Embryonic Dopamine Cell Implants for Parkinson's Disease
Trial
Phase 3
Completed
Feb. 4, 2013
Medication Review in Patients on Anti-parkinson Therapy
Trial
N/A
Completed
Feb. 3, 2013
Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients
Trial
Phase 4
Unknown
Jan. 30, 2013
PET Study in Parkinson's Disease Patients
Trial
Phase 2
Completed
Jan. 30, 2013
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Trial
Phase 3
Terminated
Jan. 30, 2013
Speech Intelligibility of Patients With P D Compared to First Degree Relatives of P D Patients
Trial
N/A
Unknown
Jan. 27, 2013
Improve Speech Using an In-the-ear Device in Parkinson's Disease
Trial
Phase 1
Completed
Jan. 17, 2013
Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms
Trial
N/A
Completed
Jan. 13, 2013
Deep Brain Stimulation and Digestive Symptomatology
Trial
N/A
Completed
Jan. 9, 2013
Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
Trial
Phase 4
Unknown
Jan. 9, 2013
Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes
Trial
N/A
Terminated
Jan. 7, 2013
Study of Antidepressants in Parkinson's Disease
Trial
Phase 3
Completed
Jan. 3, 2013
18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging
Trial
Phase 2
Completed
Dec. 26, 2012
50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease
Trial
Phase 1
Completed
Dec. 26, 2012
Transcranial Direct Current Stimulation to Treat Symptoms of Parkinson's Disease
Trial
Phase 2
Completed
Dec. 26, 2012
GM1 Ganglioside Effects on Parkinson's Disease
Trial
Phase 2
Completed
Dec. 20, 2012
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
Trial
Phase 4
Completed
Dec. 17, 2012
Brain Fitness in Parkinson's Disease
Trial
Phase 3
Completed
Dec. 9, 2012
Use of Zolpidem in Parkinson's Disease
Trial
Phase 2
Withdrawn
Dec. 2, 2012
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
Trial
Phase 4
Withdrawn
Dec. 2, 2012